Four Partners Named Life Science Stars
Robins Kaplan LLP is pleased to announce that LMG Life Sciences has recommended the firm as a top Hatch-Waxman patent litigation firm nationwide for generic pharmaceutical companies. In addition, Jake Holdreith, Jeffrey Hovden, Oren Langer, and Ronald Schutz have been named “Life Science Stars.”
- Jake Holdreith is a member of the firm’s Executive Board and the leader of the firm’s life sciences group. He has tried jury cases to multi-million-dollar verdicts and resolved complex cases at all stages of litigation. He is a skilled and creative strategist and business counselor who can cut to the heart of a matter in the boardroom and the courtroom. Based on his accomplishments, Holdreith was recently named Hatch-Waxman Litigator of the Year – Generic by LMG Life Sciences. He is ranked in the areas of General Patent Litigation, Patent Strategy & Management, and Hatch-Waxman Patent Litigation.
- Oren Langer is Managing Partner of the firm’s New York office. He focuses his practice on intellectual property and technology litigation. His experience spans various industries, including pharmaceuticals (under the Hatch-Waxman Act regulatory framework), chemicals, telecommunications, video gaming, and retail services. Langer also advises clients on licensing negotiations and campaigns, and monetizing intellectual property in anticipation of prospective mergers or acquisitions. He is ranked in the area of Hatch-Waxman Litigation.
Related Attorneys
Partner
Partner
